Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Other financing activities (2024)

Foghorn Therapeutics (FHTX) has 1 years of Other financing activities data on record, last reported at $390000.0 in Q3 2024.

  • For Q3 2024, Other financing activities changed N/A year-over-year to $390000.0; the TTM value through Dec 2025 reached $390000.0, changed 0.0%, while the annual FY2024 figure was $585000.0, N/A changed from the prior year.
  • Other financing activities reached $390000.0 in Q3 2024 per FHTX's latest filing.
  • Across five years, Other financing activities topped out at $390000.0 in Q3 2024 and bottomed at $390000.0 in Q3 2024.